Pim-3 as a Potential Predictor of Chemoradiotherapy Resistance in Locally Advanced Rectal Cancer Patients

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-16153-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Recent Advances in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Journal of the Anus, Rectum and Colon
2017English

MicroRNA Expression Profile Associated With Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Patterns of Failure in Patients With Locally Advanced Rectal Cancer Receiving Pre-Operative or Post-Operative Chemoradiotherapy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Erratum To: Kinetically Guided Neoadjuvant Chemoradiotherapy Based on 5-Fluorouracil in Patients With Locally Advanced Rectal Cancer

Clinical Pharmacokinetics
Pharmacology
2015English

Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Preoperative Chemoradiotherapy in Locally Advanced Esophageal Cancer

Acta chirurgica iugoslavica
2009English

Gene Expression Profiles of Tumor Regression Grade in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy

Oncology Reports
MedicineCancer ResearchOncology
2012English

Single Nucleotide Polymorphisms in the HIF‑1α Gene and Chemoradiotherapy of Locally Advanced Rectal Cancer

Oncology Letters
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy